Drug details

Humulin R U-500 Kwikpen (insulin human injection for subcutaneous use)

type of Antidiabetics, Insulins

Humulin R U-500 (insulin human injection) is a concentrated human insulin indicated to improve glycemic control in adults and children with diabetes mellitus requiring more than 200 units of insulin per day.

This drug may have the following side effects:

• itching,
• itching,
• rash,
• swelling,
• swelling of extremities
• bleeding,
• pain,
• bruising,
• redness,
• weight gain, and
• low blood sugar (hypoglycemia),
• allergic reactions,
  
• injection site reactions
• bumps,
• discoloration,
• warmth
• a hard lump,
• changes in distribution of body fat (lipodystrophy),

The following drugs are related to Humulin R U-500 Kwikpen, either as a replacement or used together:

• Actos (pioglitazone hydrochloride)
• Kazano (alogliptin and metformin hcl tablets)
• Oseni (alogliptin and pioglitazone tablets)
• Amaryl Tablets (glimepiride)
• Invokana (canagliflozin tablets)
• Jardiance (empagliflozin tablets)
• Glucotrol (glipizide)
• Glucotrol XL (glipizide extended release)
• Glucophage, Glucophage XR (metformin hcl)
• Glumetza (metformin hcl)
• Humulin 50-50 (50-50 human insulin isophane suspension and human insulin injection)
• Humulin 70-30 (insulin (human recombinant))
• Humulin N (insulin (human recombinant))
• Humulin R (insulin (human recombinant))
• Januvia (sitagliptin phosphate)